Responses
Late-breaking abstracts
Immune-stimulants and immune modulators
842 A novel agonistic anti-CD40 targeting strategy with an affinity peptide binding feature for antigen cargo functionality: improving peptide stability and T cell proliferation
Compose a Response to This Article
Other responses
No responses have been published for this article.
